Sign in / Join Now
ETFs & Funds
guides okay, shares down :-(
Covered Call out of it at $33. Now cycling back in a position by selling the Nov & Dec $32 puts.
down to 31.29 (since last week the call)
Nice play neo, recovered nicely today.
Add a reply...
Latest StockTalks »
people get BMY breaking news and analysis by email alert.
Get email alerts on BMY »
Bristol-Myers Squibb Company
Get latest price
From other sites
U.S. Food And Drug Administration Accepts For Priority Review The Supplemental Biologics License Application For Opdivo (nivolumab) In Previously Treated Patients With Advanced Form Of Bladder Cancer
at TheStreet (Fri, 2:19PM)
Bristol-Myers Squibb Updates Conference Call Dial-in/ID For Third Quarter 2016 Results On October 27
at TheStreet (Fri, 11:03AM)
Bristol-Myers Squibb (BMY) Q3 Earnings: What's in Store?
at Zacks.com (Fri, 9:26AM)
Bristol-Myers Squibb Foundation Joins White House Cancer Moonshot
at TheStreet (Mon, 12:15PM)
Bristol-Myers Squibb Receives Positive CHMP Opinion For Opdivo (nivolumab) For The Treatment Of Adult Patients With Relapsed Or Refractory Classical Hodgkin Lymphoma After Autologous Stem Cell Transplant And Treatment With Brentuximab Vedotin
at TheStreet (Oct 14, 2016)